The case of therapy-associated large-vessel vasculitis that we present is unique in that it contains several possible etiologies: CPI-induced vasculitis, pegfilgrastim/G-CSF induced vasculitis, or a combination with a potential immunostimulatory contribution of the PEG-containing mRNA COVID-19 vaccine. Here, CSF3 is linked to Large vessel vasculitis.